Haemonetics Corp
NYSE:HAE
Haemonetics Corp
NYSE:HAE
Price:
93.37 USD
-1.92%
Updated:
May 8, 2024
Haemonetics Corp
Cash from Operating Activities
|
Haemonetics Corp
Cash from Operating Activities Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Operating Activities
$197.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Cash from Operating Activities
$563.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Operating Activities
$423m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-1%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Operating Activities
$785.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Operating Activities
$324m
|
CAGR 3-Years
168%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
See Also
What is Haemonetics Corp's Cash from Operating Activities?
Cash from Operating Activities
197.4m
USD
197.4m
USD
Based on the financial report for Dec 30, 2023, Haemonetics Corp's Cash from Operating Activities amounts to 197.4m USD.
What is Haemonetics Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
5%
5%
Over the last year, the Cash from Operating Activities growth was -25%. The average annual Cash from Operating Activities growth rates for Haemonetics Corp have been 9% over the past three years , and 5% over the past ten years .
You don't have any saved screeners yet
